ST-segment elevation myocardial infarction (STEMI)

Find all the latest content on STEMI published on this website.

Treating STEMI brings into play a series of clinical and organizational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well…

Filtered By
STEMI

516 results

Should STEMI treatment be related to specific clinical patient characteristics

22 May 2025 – From EuroPCR 2025

This session evaluates whether STEMI treatment should be tailored to specific clinical patient characteristics. It includes insights into STEMI management in very young patients, benefits of revascularisation of LAD non-culprit lesions in older AMI patients, clinical outcomes from the NAMI registry for young STEMI patients, and...

Should STEMI treatment be related to specific clinical patient characteristics

High-risk PCI in acute coronary syndrome

22 May 2025 – From EuroPCR 2025

Explore high-risk PCI strategies in acute coronary syndrome patients who are unsuitable for surgery. This session presents insights on Killip class influence, haemodynamic support with micro-axial flow pumps, disease progression patterns in complicated STEMI, and the prognostic value of QFR-guided functional SYNTAX scores in ACS management.

High-risk PCI in acute coronary syndrome

Bifurcation CAD: presentation and PCI strategies

22 May 2025 – From EuroPCR 2025

Navigate the complexities of coronary bifurcation disease with a comprehensive session covering decision-making, imaging applications, and PCI strategies. Review clinical scenarios involving left main disease, calcifications, and acute presentations. Understand the pivotal role of intracoronary imaging and explore provisional and two-stent techniques through detailed case discussions...

Bifurcation CAD: presentation and PCI strategies

STEMI in special circumstances

22 May 2025 – From EuroPCR 2025

Address STEMI management in special circumstances such as spontaneous coronary artery dissection, ectatic vessels, and high thrombotic burden. Learn when surgical referral is appropriate and explore interventional strategies tailored to complex STEMI presentations.

STEMI in special circumstances

Extensive anterior STEMI - Treatment strategies from SCAI A to E

22 May 2025 – From EuroPCR 2025

Explore comprehensive treatment strategies for extensive anterior STEMI, focusing on risk stratification across the SCAI shock stages A to E. Learn to adapt mechanical circulatory support appropriately and understand principles guiding device selection and utilization in hemodynamic instability.

Extensive anterior STEMI - Treatment strategies from SCAI A to E

Novelty in ACS diagnosis and treatment

22 May 2025 – From EuroPCR 2025

Discover novel diagnostic and therapeutic advances in acute coronary syndrome (ACS) management. This session covers innovative topics such as paclitaxel-coated balloon angioplasty safety in STEMI, the prognostic role of carbon monoxide, AI-based ECG prediction of infarct-related arteries, microcirculatory resistance indices in MINOCA, and real-world optical coherence...

Novelty in ACS diagnosis and treatment

Role of coronary physiology in acute coronary syndrome patients

22 May 2025 – From EuroPCR 2025

Examine the role of coronary physiology in acute coronary syndrome patients, including plaque characteristics related to ACS risk, prognostic value of AngioIMR in STEMI, functional significance of lumen and plaque features, diagnostic accuracy of quantitative flow ratio, and the impact of adenosine administration routes on FFR...

Role of coronary physiology in acute coronary syndrome patients

What an interventional cardiologist should know about anti-thrombotics

22 May 2025 – From EuroPCR 2025

This session provides comprehensive knowledge on anti-thrombotic management for interventional cardiologists, emphasizing effective inhibition during acute STEMI, latest evidence implementation for high bleeding risk patients, and customization of dual antiplatelet therapy in patients with high thrombotic and low bleeding risks through clinical cases and evidence-based recommendations.

What an interventional cardiologist should know about anti-thrombotics

DCB in STEMI : why, when and how ?

22 May 2025 – From EuroPCR 2025

Explore the evolving role of drug-coated balloons (DCB) in the management of STEMI patients. This session covers practical approaches including primary PCI with DEB, unconventional solutions in urgent scenarios, and personalized treatment strategies especially in very young patients. Learn how DCB technology intersects with complex lesion...

DCB in STEMI : why, when and how ?

Calcified un-dilatable lesions in ACS: what should I do?

22 May 2025 – From EuroPCR 2025

Address the challenges of severely calcified undilatable lesions during acute coronary syndrome PCI. This session reviews the impact of coronary calcification on PCI strategy, highlights pitfalls in lesion preparation, and presents detailed case studies demonstrating effective treatment approaches.

Calcified un-dilatable lesions in ACS: what should I do?